rHV2-Lys-47

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamerHV2-Lys-47
Drug Alias NamerHV2-Lys-47
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProthrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsDisseminated Intravascular CoagulationThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene SaSanofi
Active IndicationsN/A
Inactive IndicationsDisseminated Intravascular CoagulationThrombosis

Other Information

ATC CodeN/A
Related LinksN/A